We are live on
!
Find out more
BCM
Bourgeon Capital Management Portfolio holdings
AUM
$679M
1-Year Est. Return
50.89%
This Fund
S&P 500
This Quarter
Est. Return
+13.63%
1 Year Est. Return
+50.89%
3 Year Est. Return
+117.43%
5 Year Est. Return
+128.86%
10 Year Est. Return
+553.89%
AUM
$171M
AUM Growth
+$17.7M
(+12%)
Cap. Flow
-$896K
Cap. Flow
% of AUM
-0.53%
Top 10 Holdings %
Top 10 Hldgs %
37.72%
Holding
82
New
15
Increased
20
Reduced
25
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Biotechnology ETF
IBB
|
+$3.98M |
| 2 |
Constellation Brands
STZ
|
+$3.24M |
| 3 |
DuPont de Nemours
DD
|
+$1.97M |
| 4 |
Eaton
ETN
|
+$1.77M |
| 5 |
CVS Health
CVS
|
+$1.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$4.23M |
| 2 |
Rio Tinto
RIO
|
+$2.65M |
| 3 |
Accenture
ACN
|
+$2.61M |
| 4 |
Nike
NKE
|
+$2.57M |
| 5 |
Palo Alto Networks
PANW
|
+$2.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.17% |
| 2 | Financials | 17.1% |
| 3 | Technology | 16.45% |
| 4 | Energy | 12.54% |
| 5 | Industrials | 8.56% |
Similar funds
AP
MCO
REAM
CCG
DLIC
TWM
CIA
NS
Bourgeon Capital Management's Q1 2019 Portfolio in Review
As of Q1 2019, Bourgeon Capital Management held 82 positions worth $171M, up 12% from $153M the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Bourgeon Capital Management's Q1 2019 filing shows 15 new, 20 increased, 25 reduced and 10 closed positions. Its largest new stake was iShares Biotechnology ETF: 36,330 shares worth $4.06M. The largest sale was Biogen, an estimated $4.23M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 26% a quarter earlier, followed by Financials and Technology.
- Bourgeon Capital Management's largest Q1 2019 buy was iShares Biotechnology ETF: 36,330 shares worth $4.06M.
- Bourgeon Capital Management added most to DuPont de Nemours in Q1 2019, an estimated $1.97M increase.
- Bourgeon Capital Management's biggest Q1 2019 reduction was Accenture, cutting an estimated $2.61M.
- Bourgeon Capital Management fully exited Biogen in Q1 2019, selling an estimated $4.23M.
- Bourgeon Capital Management's ten largest holdings make up 38% of its $171M portfolio in Q1 2019.
- Bourgeon Capital Management opened 15 new positions and closed 10 in Q1 2019.
- Bourgeon Capital Management's portfolio value rose 12% quarter-over-quarter to $171M.
Based on Bourgeon Capital Management's 13F filing for Q1 2019, filed 29 Apr 2019.